Logo image of NBIS

NEBIUS GROUP NV (NBIS) Stock Fundamental Analysis

NASDAQ:NBIS - NL0009805522 - Common Stock

70.02 USD
+1.04 (+1.51%)
Last: 8/25/2025, 8:00:01 PM
69.88 USD
-0.14 (-0.2%)
Pre-Market: 8/26/2025, 8:02:23 AM
Fundamental Rating

3

NBIS gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 282 industry peers in the Software industry. The financial health of NBIS is average, but there are quite some concerns on its profitability. NBIS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

NBIS had positive earnings in the past year.
The reported net income has been mixed in the past 5 years: NBIS reported negative net income in multiple years.
NBIS had a positive operating cash flow in each of the past 5 years.
NBIS Yearly Net Income VS EBIT VS OCF VS FCFNBIS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B

1.2 Ratios

NBIS's Return On Assets of 4.77% is fine compared to the rest of the industry. NBIS outperforms 73.40% of its industry peers.
With a decent Return On Equity value of 6.44%, NBIS is doing good in the industry, outperforming 71.99% of the companies in the same industry.
Industry RankSector Rank
ROA 4.77%
ROE 6.44%
ROIC N/A
ROA(3y)-2.97%
ROA(5y)-1.39%
ROE(3y)0.03%
ROE(5y)0.4%
ROIC(3y)N/A
ROIC(5y)N/A
NBIS Yearly ROA, ROE, ROICNBIS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

With an excellent Profit Margin value of 100.75%, NBIS belongs to the best of the industry, outperforming 97.16% of the companies in the same industry.
NBIS has a Gross Margin of 55.89%. This is in the lower half of the industry: NBIS underperforms 65.25% of its industry peers.
NBIS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 100.75%
GM 55.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.81%
GM growth 5Y-11.26%
NBIS Yearly Profit, Operating, Gross MarginsNBIS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K -1K -1.5K

More info and screens

6

2. Health

2.1 Basic Checks

NBIS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NBIS has been reduced compared to 1 year ago.
Compared to 5 years ago, NBIS has less shares outstanding
Compared to 1 year ago, NBIS has a worse debt to assets ratio.
NBIS Yearly Shares OutstandingNBIS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
NBIS Yearly Total Debt VS Total AssetsNBIS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B

2.2 Solvency

An Altman-Z score of 8.79 indicates that NBIS is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 8.79, NBIS belongs to the top of the industry, outperforming 83.69% of the companies in the same industry.
NBIS has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of NBIS (0.26) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z 8.79
ROIC/WACCN/A
WACC7.97%
NBIS Yearly LT Debt VS Equity VS FCFNBIS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100B 200B 300B

2.3 Liquidity

NBIS has a Current Ratio of 14.71. This indicates that NBIS is financially healthy and has no problem in meeting its short term obligations.
NBIS has a Current ratio of 14.71. This is amongst the best in the industry. NBIS outperforms 95.39% of its industry peers.
A Quick Ratio of 14.71 indicates that NBIS has no problem at all paying its short term obligations.
The Quick ratio of NBIS (14.71) is better than 95.39% of its industry peers.
Industry RankSector Rank
Current Ratio 14.71
Quick Ratio 14.71
NBIS Yearly Current Assets VS Current LiabilitesNBIS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B 250B

More info and screens

3

3. Growth

3.1 Past

NBIS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -47.99%.
Looking at the last year, NBIS shows a very negative growth in Revenue. The Revenue has decreased by -99.95% in the last year.
NBIS shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -76.82% yearly.
EPS 1Y (TTM)-47.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%839.39%
Revenue 1Y (TTM)-99.95%
Revenue growth 3Y-93.09%
Revenue growth 5Y-76.82%
Sales Q2Q%189.53%

3.2 Future

The Earnings Per Share is expected to decrease by -43.64% on average over the next years. This is quite bad
The Revenue is expected to grow by 192.26% on average over the next years. This is a very strong growth
EPS Next Y28.18%
EPS Next 2Y-26.94%
EPS Next 3Y-43.64%
EPS Next 5YN/A
Revenue Next Year312.27%
Revenue Next 2Y231.56%
Revenue Next 3Y192.26%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NBIS Yearly Revenue VS EstimatesNBIS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100B 200B 300B 400B 500B
NBIS Yearly EPS VS EstimatesNBIS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2024 2025 2026 2027 0 20 40 60 80

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NBIS is valuated quite expensively with a Price/Earnings ratio of 56.47.
The rest of the industry has a similar Price/Earnings ratio as NBIS.
NBIS is valuated expensively when we compare the Price/Earnings ratio to 27.03, which is the current average of the S&P500 Index.
NBIS is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 56.47
Fwd PE N/A
NBIS Price Earnings VS Forward Price EarningsNBIS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NBIS Per share dataNBIS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
NBIS's earnings are expected to decrease with -43.64% in the coming years. This may justify a cheaper valuation.
PEG (NY)2
PEG (5Y)N/A
EPS Next 2Y-26.94%
EPS Next 3Y-43.64%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NBIS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEBIUS GROUP NV

NASDAQ:NBIS (8/25/2025, 8:00:01 PM)

Premarket: 69.88 -0.14 (-0.2%)

70.02

+1.04 (+1.51%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)10-29 2025-10-29
Inst Owners42.85%
Inst Owner ChangeN/A
Ins Owners3.43%
Ins Owner ChangeN/A
Market Cap16.71B
Analysts82
Price Target91.19 (30.23%)
Short Float %7.31%
Short Ratio1.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-4.89%
Min Revenue beat(2)-11.6%
Max Revenue beat(2)1.82%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)43.04%
PT rev (3m)62.55%
EPS NQ rev (1m)-5.68%
EPS NQ rev (3m)97.9%
EPS NY rev (1m)99.24%
EPS NY rev (3m)99.11%
Revenue NQ rev (1m)-8.94%
Revenue NQ rev (3m)-98.91%
Revenue NY rev (1m)-98.72%
Revenue NY rev (3m)-98.78%
Valuation
Industry RankSector Rank
PE 56.47
Fwd PE N/A
P/S 69.3
P/FCF N/A
P/OCF N/A
P/B 4.43
P/tB 4.45
EV/EBITDA N/A
EPS(TTM)1.24
EY1.77%
EPS(NY)-1.81
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.01
BVpS15.82
TBVpS15.75
PEG (NY)2
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.77%
ROE 6.44%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 100.75%
GM 55.89%
FCFM N/A
ROA(3y)-2.97%
ROA(5y)-1.39%
ROE(3y)0.03%
ROE(5y)0.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.81%
GM growth 5Y-11.26%
F-ScoreN/A
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 14.71
Quick Ratio 14.71
Altman-Z 8.79
F-ScoreN/A
WACC7.97%
ROIC/WACCN/A
Cap/Depr(3y)403.95%
Cap/Depr(5y)295.35%
Cap/Sales(3y)364.92%
Cap/Sales(5y)223.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-47.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%839.39%
EPS Next Y28.18%
EPS Next 2Y-26.94%
EPS Next 3Y-43.64%
EPS Next 5YN/A
Revenue 1Y (TTM)-99.95%
Revenue growth 3Y-93.09%
Revenue growth 5Y-76.82%
Sales Q2Q%189.53%
Revenue Next Year312.27%
Revenue Next 2Y231.56%
Revenue Next 3Y192.26%
Revenue Next 5YN/A
EBIT growth 1Y-103.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year76.36%
EBIT Next 3Y79.67%
EBIT Next 5YN/A
FCF growth 1Y-175.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-70.36%
OCF growth 3Y-70.2%
OCF growth 5Y-64.62%